Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2020
Cogent Biosciences prices upsized public offering
Cogent Biosciences announced the pricing of an upsized public offering of 10,256,411 shares at $9.75 per share, with gross proceeds expected to be approximately $100 million before expenses and underwriting discounts.
2020
Cogent appoints Andrew Robbins as CEO
Cogent Biosciences announced the appointment of Andrew Robbins as President and Chief Executive Officer; he will also serve on the company's board.